The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Integrated safety analysis of venetoclax monotherapy in chronic lymphocytic leukemia (CLL).
 
Matthew Steven Davids
Consulting or Advisory Role - Abbvie; Genentech
Research Funding - Genentech
Other Relationship - Genentech
 
John F. Gerecitano
Honoraria - Abbvie; Bayer; Genentech
Consulting or Advisory Role - Abbvie; Bayer; Genentech
Other Relationship - Abbvie; Bayer; Genentech
 
Jalaja Potluri
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Elisa Cerri
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Su Young Kim
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Mark Steinberg
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Maria Verdugo
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Todd A. Busman
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Sari H. Enschede
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Mehrdad Mobasher
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Andrea Best
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Monali B Desai
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
William G. Wierda
Consulting or Advisory Role - Abbvie; Celgene; Emergent BioSolutions; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline/Novartis; Merck; Pharmacyclics; Sanofi
Research Funding - Abbvie; Acerta Pharma; Emergent BioSolutions; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Pharmacyclics